Part 2 authorized-discloser identification

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Discloser and recipient are separate

42 CFR 2.31 requires specific identification of the authorized discloser and separately identifies the recipient. Label both fields clearly. A form that says “provider” once may leave staff unable to determine which role the patient intended.

Use patient-facing wording that shows who may release the records and who will receive them. Identify a named program, lawful holder, person, or supported class on the disclosing side. Keep the recipient field, purpose, record description, and signer authority visually distinct. A signature should not validate a form whose directional roles remain ambiguous.

Build discloser choices from real lawful holders

Maintain a register with legal and public names, Part 2 program or lawful-holder status, departments, locations, roles, effective dates, aliases, records held, access boundaries, and responsible privacy contact. Use it to populate controlled consent choices. A parent company, affiliate, shared brand, vendor, billing office, HIE, or treating provider may have a relationship without fitting the discloser description the patient selected.

For a class, state objective criteria that the patient can understand and staff can test. Record included and excluded entities or roles, time period, program scope, and change trigger. Avoid classes that expand automatically with acquisitions or contractors without new review.

Classes need operational boundaries

Define organization, role, department, location, relationship, effective period, and included or excluded workforce where relevant. Before disclosure, verify that the actual sender fits the consent and has access, competence, supervision, and legal authority for the action.

At release, match the actual person or system initiating disclosure to the consent. Confirm employment or agency status, current role, program and site, access, patient records, supervision, and supported authority. A release-of-information worker may process on behalf of the named program; preserve that relationship and approval. An affiliate should not borrow another program's consent because both use one EHR.

Automated interfaces need the same match. Link sending organization, application, service account, source repository, program, data owner, and approved disclosure workflow. Block jobs whose source or actor falls outside the consent, including bulk exports and delayed batches created before organizational change.

Handle change and ambiguity before release

Review renaming, merger, acquisition, divestiture, program closure, workforce transfer, new vendor, data migration, and records moved to another lawful holder. Preserve the consent and organizational facts that existed at signing. Do not rewrite a historical field or stretch a class to fit the current holder without qualified analysis.

Use defect states such as discloser missing, ambiguous class, wrong entity, expired role, affiliate outside scope, source system mismatch, or holder uncertain. Hold the disclosure, clarify through the approved patient or legal route, and retain the original request and correction. Never ask staff to select the closest name simply to complete a queue.

Audit from both the form and the event

Sample active consents into discloser registers and access configuration. Then sample real disclosures back to the exact consent, sending entity, person or system, and record source. This catches valid-looking forms mapped to the wrong release team and actual releases made by an unauthorized affiliate.

Example with sender matching

Twenty-two disclosure requests reach release review. Twenty match an authorized person or class; two originate from an affiliate outside the consent. Sender-match readiness is 20 of 22 requests.

The program holds both requests, contacts the patient through the approved route if new consent is appropriate, and reviews whether the affiliate received earlier records. It corrects routing so the affiliate cannot enter the named program's release queue. The original 20-of-22 result remains in the audit evidence.

Authorized-discloser checklist

• Label discloser, recipient, purpose, and records as separate fields.
• Use controlled legal and public names with effective dates.
• Define classes by objective program, role, site, and holder facts.
• Match the actual person and sending system before release.
• Block affiliates, vendors, and changed roles outside consent scope.
• Hold ambiguous or outdated fields for qualified correction.
• Audit consents to access and disclosures back to disclosers.

Owner controls

The 2024 final rule provides current context. Use controlled organization and role names, form guidance, sender-to-consent matching, access rules, affiliate checks, release approval, correction routing, and audit evidence.

Monitor active disclosers, class changes, sender mismatches, wrong-affiliate requests, source-system exceptions, held releases, and corrections. Retest after program, workforce, entity, EHR, vendor, or consent changes. Preserve historical registers and release evidence.